A Phase 2, Efficacy, Safety and Tolerability Study of ALKS 3831 in Schizophrenia With Alcohol Use Disorder
Phase of Trial: Phase II
Latest Information Update: 14 Mar 2017
At a glance
- Drugs Olanzapine/samidorphan (Primary) ; Olanzapine
- Indications Alcohol-related disorders; Schizophrenia
- Focus Therapeutic Use
- Sponsors Alkermes plc
- 09 Mar 2017 Status changed from active, no longer recruiting to completed.
- 17 May 2016 Status changed from recruiting to active, no longer recruiting.
- 28 Mar 2016 Study design will be presented at the 5th Biennial Schizophrenia International Research Society (SIRS) Conference 2016, according to an Alkermes plc media release.